- Home
- MGLD vs CLNN Comparison
MGLD vs CLNN Comparison
Compare MGLD & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGLD | CLNN |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.8M | 48.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MGLD | CLNN |
|---|---|---|
| Price | $1.25 | $4.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | ★ 824.8K | 87.2K |
| Earning Date | 02-05-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $28,848,000.00 | $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $82.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $2.28 |
| 52 Week High | $1.38 | $13.50 |
Technical Indicators
Market Signals| Indicator | MGLD | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 39.12 |
| Support Level | $0.95 | $3.96 |
| Resistance Level | $1.20 | $4.41 |
| Average True Range (ATR) | 0.19 | 0.40 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 84.02 | 25.00 |
Price Performance
Historical ComparisonAbout MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.